← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2015Last known activity
Mar 16, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06890104Lead sponsorN/AMar 16, 2024
- NCT05969756Lead sponsorN/AJul 31, 2023
- NCT05969756Overall official - principal investigatorN/AJul 31, 2023
- NCT05969756Reponsible party - principal investigatorN/AJul 31, 2023
- NCT04509583Study directorN/ASep 18, 2019
- NCT04509583Lead sponsorN/ASep 18, 2019
- NCT03543774Lead sponsorPhase 4Jun 15, 2018
- NCT03543774Reponsible party - principal investigatorPhase 4Jun 15, 2018
- NCT03543774Overall official - principal investigatorPhase 4Jun 15, 2018
- NCT03825445Lead sponsorN/AApr 1, 2016
- NCT03825445Study directorN/AApr 1, 2016
- NCT02614404CollaboratorPhase 1/Phase 2Nov 1, 2015
- NCT02614404Overall official - principal investigatorPhase 1/Phase 2Nov 1, 2015
Details
- Last known activity
- Mar 16, 2024